Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

60 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Brazilian Group of Gastrointestinal Tumours' consensus guidelines for the management of gastric cancer.
Peixoto RD, Rocha-Filho DR, Weschenfelder RF, Rego JFM, Riechelmann R, Coutinho AK, Fernandes GS, Jacome AA, Andrade AC, Murad AM, Mello CAL, Miguel DSCG, Gomes DBD, Racy DJ, Moraes ED, Akaishi EH, Carvalho ES, Mello ES, Filho FM, Coimbra FJF, Capareli FC, Arruda FF, Vieira FMAC, Takeda FR, Cotti GCC, Pereira GLS, Paulo GA, Ribeiro HSC, Lourenco LG, Crosara M, Toneto MG, Oliveira MB, de Lourdes Oliveira M, Begnami MD, Forones NM, Yagi O, Ashton-Prolla P, Aguillar PB, Amaral PCG, Hoff PM, Araujo RLC, Filho RPDP, Gansl RC, Gil RA, Pfiffer TEF, Souza T, Jr UR, Jesus VHF, Jr WLC, Prolla G. Peixoto RD, et al. Among authors: gil ra. Ecancermedicalscience. 2020 Oct 20;14:1126. doi: 10.3332/ecancer.2020.1126. eCollection 2020. Ecancermedicalscience. 2020. PMID: 33209117 Free PMC article. Review.
GUIDELINE FOR THE MANAGEMENT OF BILE DUCT CANCERS BY THE BRAZILIAN GASTROINTESTINAL TUMOR GROUP.
Riechelmann R, Coutinho AK, Weschenfelder RF, Andrade DE Paulo G, Fernandes Gdos S, Gifoni M, Oliveira Mde L, Gansl R, Gil R, Luersen G, Lucas L, Reisner M, Vieira FM, Machado MA, Murad A, Osvaldt A, Brandão M, Carvalho E, Souza T, Pfiffer T, Prolla G. Riechelmann R, et al. Arq Gastroenterol. 2016 Jan-Mar;53(1):5-9. doi: 10.1590/S0004-28032016000100003. Arq Gastroenterol. 2016. PMID: 27276097 Free article.
Brazilian Group of Gastrointestinal Tumours' consensus guidelines for the management of oesophageal cancer.
Rocha-Filho DR, Peixoto RD, Weschenfelder RF, Rego JFM, Riechelmann R, Coutinho AK, Fernandes GS, Jacome AA, Andrade AC, Murad AM, Mello CAL, Miguel DSCG, Gomes DBD, Racy DJ, Moraes ED, Akaishi EH, Carvalho ES, Mello ES, Filho FM, Coimbra FJF, Capareli FC, Arruda FF, Vieira FMAC, Takeda FR, Cotti GCC, Pereira GLS, Paulo GA, Ribeiro HSC, Lourenco LG, Crosara M, Toneto MG, Oliveira MB, de Lourdes Oliveira M, Begnami MD, Forones NM, Yagi O, Ashton-Prolla P, Aguillar PB, Amaral PCG, Hoff PM, Araujo RLC, Di Paula Filho RP, Gansl RC, Gil RA, Pfiffer TEF, Souza T, Ribeiro U Jr, Jesus VHF, Costa WL Jr, Prolla G. Rocha-Filho DR, et al. Among authors: gil ra. Ecancermedicalscience. 2021 Mar 2;15:1195. doi: 10.3332/ecancer.2021.1195. eCollection 2021. Ecancermedicalscience. 2021. PMID: 33889204 Free PMC article.
Later lines of systemic therapy in patients with metastatic colorectal cancer: real-world data from a setting with barriers to access cancer therapies.
Jácome AA, Mathias-Machado MC, Gil M, Passarini TM, Cristofaro S, Moraes ED, Freitas LVW, Prolla G, Amorim LC, Paes RD, Gasparotto B, Canedo J, Ferreira CG, Ferrari B, Garicochea B, Gil R, Peixoto RD. Jácome AA, et al. J Gastrointest Oncol. 2024 Dec 31;15(6):2543-2551. doi: 10.21037/jgo-24-524. Epub 2024 Dec 28. J Gastrointest Oncol. 2024. PMID: 39816030 Free PMC article.
A Randomized Phase 3 Study Comparing P2B001 to its Components (Low-Dose Extended-Release Rasagiline and Pramipexole) and to Optimized Doses of Marketed Extended-Release Pramipexole in Early Parkinson's Disease.
Olanow CW, Hauser RA, Burdick DJ, Dhall R, de Marcaida JA, Gil RA, Kreitzman DL, Elmer LW, McGarry A, Kieburtz K; P2B Study Group. Olanow CW, et al. Among authors: gil ra. Mov Disord. 2024 Feb;39(2):350-359. doi: 10.1002/mds.29642. Epub 2023 Oct 27. Mov Disord. 2024. PMID: 37886872 Clinical Trial.
60 results